A detailed history of Cwm, LLC transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Cwm, LLC holds 503 shares of CTKB stock, worth $3,083. This represents 0.0% of its overall portfolio holdings.

Number of Shares
503
Previous 1,044 51.82%
Holding current value
$3,083
Previous $6,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$4.73 - $6.73 $2,558 - $3,640
-541 Reduced 51.82%
503 $3,000
Q2 2024

Jul 09, 2024

BUY
$5.3 - $6.91 $4,499 - $5,866
849 Added 435.38%
1,044 $6,000
Q4 2023

Feb 01, 2024

SELL
$4.1 - $9.51 $4,231 - $9,814
-1,032 Reduced 84.11%
195 $2,000
Q3 2023

Oct 11, 2023

BUY
$5.52 - $9.5 $3,963 - $6,821
718 Added 141.06%
1,227 $7,000
Q2 2023

Aug 03, 2023

BUY
$6.69 - $11.99 $2,381 - $4,268
356 Added 232.68%
509 $4,000
Q1 2023

Apr 28, 2023

BUY
$8.44 - $13.47 $1,190 - $1,899
141 Added 1175.0%
153 $1,000
Q4 2022

Feb 01, 2023

BUY
$9.71 - $15.86 $116 - $190
12 New
12 $0

Others Institutions Holding CTKB

About Cytek Biosciences, Inc.


  • Ticker CTKB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 134,627,008
  • Market Cap $825M
  • Description
  • Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...
More about CTKB
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.